Streetbeat News

Stock Prices

SBUX

The article discusses recent options trading activity for Starbucks (NASDAQ:SBUX), highlighting a bullish sentiment among traders. Despite a slight decrease in stock price, analysts have set varied price targets, with some upgrading and others downgrading their ratings. The options market shows significant interest in a price range of $85 to $105.

Portfolio Pulse from Benzinga Insights

October 03, 2024 | 4:20 pm

PFE

The article discusses recent options trading trends for Pfizer (NYSE:PFE), highlighting a balanced sentiment among traders with significant call and put options activity. The price target for Pfizer is between $28.0 and $32.0, with a consensus analyst target of $45.0. The stock is currently trading at $28.34, down 0.93%.

Portfolio Pulse from Benzinga Insights

October 03, 2024 | 4:20 pm

DIS

NFLX

PARA

WBD

Streaming companies' shares are declining as Amazon plans to increase its Prime Video advertising spend.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 4:18 pm

AMZN

Morgan Stanley analyst Brian Nowak reiterated an Overweight rating for Amazon with a $210 price target, citing growth in free cash flow and efficiency gains. Despite short-term profit challenges, Amazon's focus on essentials and corporate efficiencies are expected to drive growth.

Portfolio Pulse from Anusuya Lahiri

October 03, 2024 | 4:14 pm

ANGO

ELAB

KXIN

NGVT

TOVX

U.S. stocks showed mixed performance with the Nasdaq Composite gaining slightly. Crude oil prices jumped over 4%, while the U.S. services PMI was revised lower. Notable stock movements included Elevai Labs Inc. surging 67% and AngioDynamics, Inc. dropping 19% after earnings results.

Portfolio Pulse from Avi Kapoor

October 03, 2024 | 4:12 pm

EQIX

SRHR

SRVR

Equinix, Inc. (NASDAQ:EQIX) announced a $15 billion joint venture with GIC and CPP Investments to expand its xScale data centers globally, focusing on AI and cloud growth. Equinix will own 25% of the JV, which aims to triple the xScale program's investment capital. EQIX shares are down 0.98%.

Portfolio Pulse from Lekha Gupta

October 03, 2024 | 4:02 pm

BLBD

In the past three months, six analysts have shared their evaluations of Blue Bird (NASDAQ:BLBD), with a range of ratings from bullish to bearish. The average 12-month price target has increased by 9.1% to $62.0. Blue Bird has shown strong financial performance with a 13.28% revenue growth rate, a net margin of 8.61%, and a return on equity of 23.62%.

Portfolio Pulse from Benzinga Insights

October 03, 2024 | 4:01 pm

MODV

Analysts have provided mixed ratings for ModivCare (NASDAQ:MODV) over the past three months, with a recent average price target of $24.0, down 25.58% from previous estimates. The company's financials show challenges in revenue growth and debt management, despite a strong market position.

Portfolio Pulse from Benzinga Insights

October 03, 2024 | 4:00 pm

EPRT

The article provides an in-depth analysis of 12 analyst recommendations for Essential Props Realty (NYSE:EPRT), highlighting a mix of bullish and bearish perspectives. Analysts have set a 12-month average price target of $33.94, up 9.41% from the previous target. The company's financial performance is strong, with significant revenue growth, high net margins, and efficient debt management.

Portfolio Pulse from Benzinga Insights

October 03, 2024 | 4:00 pm

CRC

Analysts have provided mixed ratings for California Resources (NYSE:CRC) over the past three months, with a slight upward trend in price targets. The company faces challenges in revenue growth, profitability, and financial performance compared to industry averages.

Portfolio Pulse from Benzinga Insights

October 03, 2024 | 4:00 pm